ASN Kidney Transplantation 2021 Update
Content
- Acute Rejection and Banff Classification
- Basic Immunology of Transplantation for Clinicians
- COVID-19 in Kidney Transplant Patients
- Disparities in Access to Kidney Transplantation
- Evaluation of Living Kidney Donors, Including Medically Complex Patients
- Immunological Assessment and HLA and Epitope Matching
- Immunosuppressive Regimens and Outcomes
- Medical Evaluation of Potential Recipients
- Optimizing Deceased Donor Allocation
- Outcomes, Risk Assessment, and Ethical Considerations for Living Donors
- Pharmacology of Immunosuppressive Agents, Drug-Drug Interactions, and Adverse Effects
- Polyomaviruses and Cytomegalovirus
- Post-Transplant Malignancies
- Recurrent Glomerular Disease
- What’s in the Pipeline Future Developments in Transplantation